2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on EGFR+ NSCLC: Adjuvant Gefitinib, Adjuvant Osimertinib, Bevacizumab + Erlotinib Final Survival Analysis
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Shayma Kazmi
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Shayma Kazmi
101 views
September 22, 2020
Comments 0
Login to view comments.
Click here to Login
Lung